Results 241 to 250 of about 127,504 (263)

PCSK9 Association With Lipoprotein(a)

Circulation Research, 2016
Gilles Lambert, Hagai Tavori
exaly  

Atherogenic Lipoprotein Particles in Atherosclerosis

Circulation, 2004
Patrick Duriez, Rafael Carmena
exaly  

Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events

Circulation, 2017
Samia Mora, Amit Khera, Robert Glynn
exaly  

Lipoprotein receptors and cholesterol homeostasis

Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
R W, Mahley, T L, Innerarity
openaire   +2 more sources

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis

Circulation, 2008
Steven Nissen, Jean-Claude Tardif, Stephen Nicholls   +2 more
exaly  

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events

Journal of the American Heart Association, 2020
Nandhini Sehar, Lena Tschiderer
exaly  

[Lipoprotein receptor].

Nihon rinsho. Japanese journal of clinical medicine, 1991
T, Ishikawa, A, Kagami
openaire   +1 more source

Loss of Plasma Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) After Lipoprotein Apheresis

Circulation Research, 2013
Hagai Tavori, Sérgio Fazio, Macrae Linton   +2 more
exaly  

Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)

Circulation Research, 2017
Sally Mccormick, Gregory Redpath, Michael Williams   +2 more
exaly  

Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes

Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
, Manuel Mayr, Joseph Witztum
exaly